We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

105 hedge funds and large institutions have $678M invested in Myovant Sciences Ltd. in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 37

3% less funds holding

Funds holding: 108 → 105 (-3)

8% less capital invested

Capital invested by funds: $737M → $678M (-$59M)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

69% less call options, than puts

Call options by funds: $7.65M | Put options by funds: $24.7M

Holders
105
Holders Change
-3
Holders Change %
-2.78%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
34
Reduced
37
Closed
16
Calls
$7.65M
Puts
$24.7M
Net Calls
-$17M
Net Calls Change
+$7.03M

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$11M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$5.67M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$3.79M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.35M
5
JF
Jump Financial
Illinois
+$2.05M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$43.5M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$5.61M
3
CAM
Cormorant Asset Management
Massachusetts
-$5.32M
4
MWNA
Marshall Wace North America
New York
-$4.39M
5
ECM
ExodusPoint Capital Management
New York
-$3.99M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$2.9M -$1.09M -49,594 -28%
BAM
27
Blueshift Asset Management
New Jersey
$2.85M -$904K -41,175 -24%
Rafferty Asset Management
28
Rafferty Asset Management
New York
$2.55M -$36.4K -1,657 -1%
Citigroup
29
Citigroup
New York
$2.28M -$1.65M -75,034 -43%
Morgan Stanley
30
Morgan Stanley
New York
$2.13M -$3.19M -145,098 -60%
Northern Trust
31
Northern Trust
Illinois
$2.1M +$64.3K +2,929 +3%
JF
32
Jump Financial
Illinois
$2.09M +$2.05M +93,274 New
SF
33
Synovus Financial
Georgia
$1.94M -$52.3K -2,384 -3%
ACM
34
ACT Capital Management
Pennsylvania
$1.91M -$54.9K -2,500 -3%
Swiss National Bank
35
Swiss National Bank
Switzerland
$1.81M +$17.6K +800 +1%
TIP
36
Torray Investment Partners
Maryland
$1.67M +$13.2K +601 +0.8%
CAPTRUST Financial Advisors
37
CAPTRUST Financial Advisors
North Carolina
$1.57M +$552K +25,133 +56%
IHAM
38
Integral Health Asset Management
New York
$1.46M -$439K -20,000 -24%
LBA
39
Letko, Brosseau & Associates
Quebec, Canada
$1.42M – – –
AS
40
Altshuler Shaham
Israel
$1.04M +$1.01M +46,219 New
CSS
41
Cubist Systematic Strategies
Connecticut
$1.02M +$729K +33,204 +269%
Two Sigma Investments
42
Two Sigma Investments
New York
$1.01M +$991K +45,136 New
Cambridge Investment Research Advisors
43
Cambridge Investment Research Advisors
Iowa
$875K – – –
Jane Street
44
Jane Street
New York
$788K -$707K -32,211 -48%
UBS AM
45
UBS AM
Illinois
$728K – – –
Rockefeller Capital Management
46
Rockefeller Capital Management
New York
$718K -$54.9K -2,500 -7%
Fidelity Investments
47
Fidelity Investments
Massachusetts
$714K -$1.73M -78,753 -71%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$673K +$658K +29,971 New
Wells Fargo
49
Wells Fargo
California
$654K -$28.9K -1,318 -4%
TFO
50
Tarbox Family Office
California
$617K -$319K -14,540 -35%
1
2
3 4 5

MYOV Hedge Fund Activity: Q3 2021 in Review

105 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q3 2021, worth a combined $678M — down 8% from $737M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of MYOV and 14 opened new positions — a net loss of 2 holders — while 37 trimmed existing stakes and 34 added.

The largest buyer was Bellevue Group, adding an estimated $11M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $43.5M sold.

  • 105 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q3 2021, down from 108 in Q2 2021.
  • Funds reported $678M of Myovant Sciences Ltd. stock for Q3 2021, down 8% quarter-over-quarter.
  • 14 funds opened new Myovant Sciences Ltd. positions in Q3 2021 and 16 closed out, a net change of -2 holders.
  • The largest Myovant Sciences Ltd. buyer in Q3 2021 was Bellevue Group, an estimated $11M added.
  • The largest Myovant Sciences Ltd. seller in Q3 2021 was PFM Health Sciences, an estimated $43.5M sold.

Based on aggregated 13F filings for Q3 2021.